Literature DB >> 7947874

Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.

J Jarcho1, D C Naftel, T W Shroyer, J K Kirklin, R C Bourge, M L Barr, D G Pitts, R C Starling.   

Abstract

HLA mismatch has been shown to influence survival after heart transplantation. No large multicenter study has examined the effect of HLA mismatch on cardiac allograft rejection. HLA mismatch and other potential risk factors for rejection were analyzed in data from 27 institutions (1719 patients) participating in the Cardiac Transplant Research Database between January 1, 1990, and June 30, 1992. Complete HLA information on the A, B, and DR loci was available for both donor and recipient in 1190 patients. Of these, 619 (52%) had five or six mismatches; 68 (6%) had zero, one, or two mismatches. The mean number of mismatches was 4.4 and did not differ, regardless of donor-recipient race match (4.3 versus 4.8, p = 0.19). According to multivariate analysis, risk factors for time to first rejection included younger recipient age (p < 0.0001), female gender of both donor and recipient (p < 0.0006), number of HLA mismatches (p = 0.013) and black recipient race (p < 0.004). Patients with zero, one, or two mismatches (n = 67) had a 54% freedom from rejection at 1 year versus 36% for patients with three or more mismatches (n = 1005, p = 0.02). HLA mismatch number did not affect time to first rejection or rejection frequency among black patients. Risk factors (by multivariate analysis) for death or retransplantation because of rejection included female recipient gender (p = 0.008) and black recipient race (p = 0.006). The probability of rejection-related death or retransplantation by 2 years was 0% with zero, one, or two HLA mismatches versus 5% for three to six mismatches (p = 0.14). These findings should stimulate further investigation of methods to clarify the HLA effect in heart transplantation and eventually the use of HLA typing in donor-recipient selection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947874

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

Review 1.  Small cells, big effects: the role of platelets in transplant vasculopathy.

Authors:  Kristina L Modjeski; Craig N Morrell
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

Review 2.  Combined cardio-renal transplantation (CCRT) from the same donor: report of two cases and review of the literature.

Authors:  B M Mistry; M A Memon; B Jepson; H Solomon; R Ruggiero; L McBride; P J Garvin
Journal:  Ann R Coll Surg Engl       Date:  2001-09       Impact factor: 1.891

Review 3.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

5.  The influence of human leukocyte antigen matching on outcomes in pediatric heart transplantation.

Authors:  Salil Ginde; Thomas M Ellis; Melodee Nugent; Pippa Simpson; Gail Stendahl; Stuart Berger; Steven Zangwill
Journal:  Pediatr Cardiol       Date:  2014-04-23       Impact factor: 1.655

Review 6.  Applying genomics in heart transplantation.

Authors:  Brendan J Keating; Alexandre C Pereira; Michael Snyder; Brian D Piening
Journal:  Transpl Int       Date:  2018-02-12       Impact factor: 3.782

Review 7.  Outcomes following cardiac transplantation in adults.

Authors:  Sai Bhagra; Jayan Parameshwar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-02-15

Review 8.  Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap.

Authors:  Alanna A Morris; Evan P Kransdorf; Bernice L Coleman; Monica Colvin
Journal:  J Heart Lung Transplant       Date:  2016-02-12       Impact factor: 10.247

Review 9.  The challenge of rejection and cardiac allograft vasculopathy.

Authors:  W G Cotts; M R Johnson
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

Review 10.  Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.

Authors:  Antonietta Picascia; Vincenzo Grimaldi; Amelia Casamassimi; Maria Rosaria De Pascale; Concetta Schiano; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2014-09-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.